2024-04-012025-03-312025-03-31false11237471WESTMINSTER MEDICAL GROUP LIMITED2025-05-0886210falseiso4217:GBPxbrli:pure112374712024-03-31112374712025-03-31112374712024-04-012025-03-31112374712023-03-31112374712024-03-31112374712023-04-012024-03-3111237471bus:SmallEntities2024-04-012025-03-3111237471bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3111237471bus:AbridgedAccounts2024-04-012025-03-3111237471bus:PrivateLimitedCompanyLtd2024-04-012025-03-3111237471core:WithinOneYear2025-03-3111237471core:AfterOneYear2025-03-3111237471core:WithinOneYear2024-03-3111237471core:AfterOneYear2024-03-3111237471core:ShareCapital2025-03-3111237471core:SharePremium2025-03-3111237471core:RevaluationReserve2025-03-3111237471core:OtherReservesSubtotal2025-03-3111237471core:RetainedEarningsAccumulatedLosses2025-03-3111237471core:ShareCapital2024-03-3111237471core:SharePremium2024-03-3111237471core:RevaluationReserve2024-03-3111237471core:OtherReservesSubtotal2024-03-3111237471core:RetainedEarningsAccumulatedLosses2024-03-3111237471core:LandBuildings2025-03-3111237471core:PlantMachinery2025-03-3111237471core:Vehicles2025-03-3111237471core:FurnitureFittings2025-03-3111237471core:OfficeEquipment2025-03-3111237471core:NetGoodwill2025-03-3111237471core:IntangibleAssetsOtherThanGoodwill2025-03-3111237471core:ListedExchangeTraded2025-03-3111237471core:UnlistedNon-exchangeTraded2025-03-3111237471core:LandBuildings2024-03-3111237471core:PlantMachinery2024-03-3111237471core:Vehicles2024-03-3111237471core:FurnitureFittings2024-03-3111237471core:OfficeEquipment2024-03-3111237471core:NetGoodwill2024-03-3111237471core:IntangibleAssetsOtherThanGoodwill2024-03-3111237471core:ListedExchangeTraded2024-03-3111237471core:UnlistedNon-exchangeTraded2024-03-3111237471core:LandBuildings2024-04-012025-03-3111237471core:PlantMachinery2024-04-012025-03-3111237471core:Vehicles2024-04-012025-03-3111237471core:FurnitureFittings2024-04-012025-03-3111237471core:OfficeEquipment2024-04-012025-03-3111237471core:NetGoodwill2024-04-012025-03-3111237471core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111237471core:ListedExchangeTraded2024-04-012025-03-3111237471core:UnlistedNon-exchangeTraded2024-04-012025-03-3111237471core:MoreThanFiveYears2024-04-012025-03-3111237471core:Non-currentFinancialInstruments2025-03-3111237471core:Non-currentFinancialInstruments2024-03-3111237471dpl:CostSales2024-04-012025-03-3111237471dpl:DistributionCosts2024-04-012025-03-3111237471core:LandBuildings2024-04-012025-03-3111237471core:PlantMachinery2024-04-012025-03-3111237471core:Vehicles2024-04-012025-03-3111237471core:FurnitureFittings2024-04-012025-03-3111237471core:OfficeEquipment2024-04-012025-03-3111237471dpl:AdministrativeExpenses2024-04-012025-03-3111237471core:NetGoodwill2024-04-012025-03-3111237471core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111237471dpl:GroupUndertakings2024-04-012025-03-3111237471dpl:ParticipatingInterests2024-04-012025-03-3111237471dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3111237471core:ListedExchangeTraded2024-04-012025-03-3111237471dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3111237471core:UnlistedNon-exchangeTraded2024-04-012025-03-3111237471dpl:CostSales2023-04-012024-03-3111237471dpl:DistributionCosts2023-04-012024-03-3111237471core:LandBuildings2023-04-012024-03-3111237471core:PlantMachinery2023-04-012024-03-3111237471core:Vehicles2023-04-012024-03-3111237471core:FurnitureFittings2023-04-012024-03-3111237471core:OfficeEquipment2023-04-012024-03-3111237471dpl:AdministrativeExpenses2023-04-012024-03-3111237471core:NetGoodwill2023-04-012024-03-3111237471core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3111237471dpl:GroupUndertakings2023-04-012024-03-3111237471dpl:ParticipatingInterests2023-04-012024-03-3111237471dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3111237471core:ListedExchangeTraded2023-04-012024-03-3111237471dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3111237471core:UnlistedNon-exchangeTraded2023-04-012024-03-3111237471core:NetGoodwill2025-03-3111237471core:IntangibleAssetsOtherThanGoodwill2025-03-3111237471core:LandBuildings2025-03-3111237471core:PlantMachinery2025-03-3111237471core:Vehicles2025-03-3111237471core:FurnitureFittings2025-03-3111237471core:OfficeEquipment2025-03-3111237471core:AfterOneYear2025-03-3111237471core:WithinOneYear2025-03-3111237471core:ListedExchangeTraded2025-03-3111237471core:UnlistedNon-exchangeTraded2025-03-3111237471core:ShareCapital2025-03-3111237471core:SharePremium2025-03-3111237471core:RevaluationReserve2025-03-3111237471core:OtherReservesSubtotal2025-03-3111237471core:RetainedEarningsAccumulatedLosses2025-03-3111237471core:NetGoodwill2024-03-3111237471core:IntangibleAssetsOtherThanGoodwill2024-03-3111237471core:LandBuildings2024-03-3111237471core:PlantMachinery2024-03-3111237471core:Vehicles2024-03-3111237471core:FurnitureFittings2024-03-3111237471core:OfficeEquipment2024-03-3111237471core:AfterOneYear2024-03-3111237471core:WithinOneYear2024-03-3111237471core:ListedExchangeTraded2024-03-3111237471core:UnlistedNon-exchangeTraded2024-03-3111237471core:ShareCapital2024-03-3111237471core:SharePremium2024-03-3111237471core:RevaluationReserve2024-03-3111237471core:OtherReservesSubtotal2024-03-3111237471core:RetainedEarningsAccumulatedLosses2024-03-3111237471core:NetGoodwill2023-03-3111237471core:IntangibleAssetsOtherThanGoodwill2023-03-3111237471core:LandBuildings2023-03-3111237471core:PlantMachinery2023-03-3111237471core:Vehicles2023-03-3111237471core:FurnitureFittings2023-03-3111237471core:OfficeEquipment2023-03-3111237471core:AfterOneYear2023-03-3111237471core:WithinOneYear2023-03-3111237471core:ListedExchangeTraded2023-03-3111237471core:UnlistedNon-exchangeTraded2023-03-3111237471core:ShareCapital2023-03-3111237471core:SharePremium2023-03-3111237471core:RevaluationReserve2023-03-3111237471core:OtherReservesSubtotal2023-03-3111237471core:RetainedEarningsAccumulatedLosses2023-03-3111237471core:AfterOneYear2024-04-012025-03-3111237471core:WithinOneYear2024-04-012025-03-3111237471core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3111237471core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3111237471core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3111237471core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3111237471core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3111237471core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3111237471core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111237471core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111237471core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3111237471core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3111237471core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3111237471core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3111237471core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3111237471core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3111237471core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3111237471core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3111237471core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3111237471core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3111237471core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3111237471core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3111237471core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3111237471core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3111237471core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3111237471core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3111237471core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3111237471core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3111237471core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3111237471bus:Director12024-04-012025-03-31

WESTMINSTER MEDICAL GROUP LIMITED

Registered Number
11237471
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

WESTMINSTER MEDICAL GROUP LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

IRVINE, James Robert John

Registered Address

134 Harley Street
London
W1G 7JY

Registered Number

11237471 (England and Wales)
WESTMINSTER MEDICAL GROUP LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Current assets
Debtors18,849-
Cash at bank and on hand10,07710,034
28,92610,034
Creditors amounts falling due within one year(7,187)(7,735)
Net current assets (liabilities)21,7392,299
Total assets less current liabilities21,7392,299
Creditors amounts falling due after one year(21,639)(13,770)
Net assets100(11,471)
Capital and reserves
Called up share capital100100
Profit and loss account-(11,571)
Shareholders' funds100(11,471)
The financial statements were approved and authorised for issue by the Director on 8 May 2025, and are signed on its behalf by:
IRVINE, James Robert John
Director
Registered Company No. 11237471
WESTMINSTER MEDICAL GROUP LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

20252024
Average number of employees during the year21